Introduction: Three Essentials You Cannot Refuse
You can refuse a luxury good. You cannot refuse three things: the ability to see (you need glasses to work, drive, read); the ability to live (you need medicine when the body fails); and the ability to know where public money went (you need an audit you can trust). These are not consumer choices. They are the floor under everything else.
And on all three floors, capital built a monopoly. Not out of malice — out of the same three-legged structure: an essential you cannot exit, a gatekeeper who is also the seller, and no substitute for the only door. Any market built on those three legs becomes a monopoly, whatever the intention.
That era is now ending. Not because capital grew a conscience, but because the tools changed — and the one thing a monopoly cannot survive is a cheap substitute for its gate.
The Great Transfer: Forty Years of Handing Over the Essentials
For most of the twentieth century, the answer to "who provides the essentials?" was the state. Water, electricity, rail, the postal service, schooling, medicine, the audit of public accounts, even the issuing of money — these sat on the public side of the line. Not because officials were virtuous, but because the alternative was worse: a private owner free to charge whatever survival could bear.
That default was reversed. From 1979 onward — Thatcher in Britain, Reagan in the United States — privatization was sold as efficiency; by 1989 the formula had a name, the Washington Consensus, and a delivery mechanism: loan conditions attached to structural adjustment. What could not be sold outright was contracted out; what could not be contracted out was "reformed" until it behaved like a market.
The record is not subtle. British water and rail went to private operators who kept the revenue and handed the failures back to the public. California's electricity market was designed so thin that traders could extract from it — and the lights went out in 2001. In Cochabamba, Bolivia, a consortium was given the city's water in 1999; when the rates rose, the city fought, and the contract was cancelled in 2000. Across the Global South the same conditions arrived with the same signature: cut public capacity first, then buy the service back at a price.
The mechanism is not the sale of an asset. It is a swap: the public builds, the private collects; the public carries the downside, the private keeps the upside. A road, a grid, a hospital, a statistical office — paid for by everyone, rented back to everyone.
And the list of essentials did not shrink. It grew. Once a society accepts that survival can be priced, the set expands outward: the ability to see, the ability to live, the ability to know where public money went, a place to live, a way into the modern economy, a dignified death. Each one is now an address where rent can be charged.
So the subject here is not four bad firms or one bad industry. It is a transfer of a governing paradigm: the state moved from provider to purchaser, from referee to client, from host to tenant. The Big Four are simply what that paradigm looks like when it reaches the one thing a society cannot outsource twice — the production of its own truth.
This is not three monopolies. It is one transfer: forty years of handing over, item by item, what a person needs in order to live — and calling the rent an efficiency.
What ends now is the arithmetic that made the transfer look permanent. When verification is open-source, when public buyers can bargain together, when a public manufacturer can build what the market refuses to build, the rent has nowhere left to hide.
The Boundary of Necessity
Transnational capital runs on one predatory logic: find a group with no bargaining power, turn its survival needs into "services you are obliged to buy," and seal off every alternative with patents, law, and technology.
But there is a structural boundary that logic cannot cross. Water, food, healthcare, housing, and financial auditing are the foundation of human survival and of state sovereignty. They are not financial derivatives built to inflate a quarterly report.
When capital monopolizes the necessities of life — the patent thicket of medicine, the compliance black box of the Big Four, the monopoly pricing of everyday eyewear — it stops being an engine of progress. It becomes a parasite.
Cost must never be transferred to those with no voice to refuse it.
The system will not fall because of moral outrage. It will fall because of arithmetic: when the cost of maintaining the monopoly exceeds the cost of abandoning it, the old paradigm breaks. Open mathematics and efficient supply chains are already handing over the alternative. The monopoly on human survival has to end.
One · Eyewear: The Right to See
Vision is not optional: without glasses, a person cannot drive, work, or read. So the eyewear market has almost no "refusal power" — when you need to see, you buy what is on the shelf.
And one group owns the shelf. EssilorLuxottica, formed when the French lens maker Essilor merged with the Italian frame-and-retail giant Luxottica in 2018 (and added the retailer GrandVision in 2021), makes the lenses, owns the brands — Ray-Ban, Oakley, Persol and more — and runs the stores where the sale happens: Sunglass Hut, LensCrafters, Pearle Vision. The optician who "recommends" works behind a counter the brand paid for.
The signs of the end are already here: direct-to-consumer brands that sell frames without the retail stack; online prescription and transparent pricing; independent opticians returning; and competition law that can break the vertical stack. The gate is no longer the only door.
Two · Medicine: The Right to Live
Medicine is the sharpest case, because the stake is survival. The monopoly here is not a single patent but a system of locks: "evergreening" (tiny changes that extend a patent again and again), "pay-for-delay" (paying generic makers to launch later), and a middle layer of pharmacy benefit managers that decides which drug flows where.
The result is public: the same insulin sells in the United States for several times what it costs in many other developed countries; the EpiPen's price multiplied several times over a decade while the product barely changed. People ration insulin — not because it is scarce, but because the gate is priced.
The signs of the end: faster generic entry, patent reform against evergreening, transparent pricing, and public purchasing power — governments bargaining together, buying across borders, building public manufacturing where the market will not.
Three · The Audit of Government: The Right to Know
The third essential is the quietest: knowing where the public money went. A state's books are audited so that citizens can trust the numbers. But that power, too, was handed to capital — the audit Big Four (Deloitte, PwC, EY, KPMG) — and then the state outsourced its own oversight to the same four firms.
The result: stamping replaced auditing (Wirecard's €1.9 billion of assets that did not exist, signed by EY; Carillion's clean opinion from KPMG before collapse), and the treasury was drained while the books looked clean. When the auditor is also the consultant, and the state is also the client, the certificate of honesty is sold by the party being audited.
The signs of the end: open-source verification (Open Audit Core lets anyone cross-check a ledger), public audit capacity, and the return of the power to accept an opinion to the public.
The Same Machine in All Three
Put the three side by side and one structure appears:
Essential demand. You cannot exit — you must see, must live, must know. Demand does not fall when price rises; it is captured.
Gatekeeper is the seller. The brand owns the store; the consultant signs the audit; the patent-holder sets the price through the middle layer.
No substitute at the gate. One shelf, one set of stamps, one patent — so "shopping around" and "second opinion" are illusions.
Profit from capture, not from quality. The margin comes from being unavoidable, not from being better. That is why quality can fall while price rises, and the monopoly still grows.
None of these three monopolies became rich by serving people better. They became rich by making themselves impossible to avoid. That is the whole machine: turn an essential into a tollbooth.
Four More Doors: The Rest of This Series
The three cases above are the ones most often argued in public. The machine does not stop there. Four chapters follow — one per lock — and each ends with a way out, not a verdict.
Chapter One · The Seed Lock. Food is the bottom essential, and its first step is a seed. Four firms sell the seed and design the trait that decides which pesticide must be bought with it: the seed is the key, the pesticide is the lock. In Monsanto v. Bowman (2013) the rule was stated plainly: you may buy the seed, but you may not let it reproduce. A civilization that cannot keep its own seed has not secured its food — it rents it, season by season. Read chapter one →
Chapter Two · Where the Ground Is Locked. Shelter is the only essential that is also an asset and a tax base. Supply is not blocked by a company but by a permission — zoning, planning consent, land registry, tax treatment. The public pays for the infrastructure, the private collects the uplift: value capture run in reverse. Read chapter two →
Chapter Three · The Toll on Entry. Three layers — the rails (Visa, Mastercard), the store (Apple and Google taking 30%), and trust itself (Equifax, Experian, TransUnion). The gatekeeper is the fee collector in its purest form. Brazil's Pix and India's UPI already prove the toll can be dismantled. Read chapter three →
Chapter Four · The Last Door. Death is the only demand that does not fall when the price rises: it happens once, cannot be postponed, cannot be returned, cannot be shopped around. Grief carries a premium, and it lasts exactly as long as a family's ability to say no — one hour in a lifetime. Read chapter four →
Four locks, one machine: patent in the seed, permission in the land, commission in the digital gate, grief in the last door.
Why the Era Is Ending — and What Remains to Be Fought
The era ends not because capital repented, but because three things now make avoidance cheap:
Tools got cheap. Open-source verification, direct-to-consumer distribution, online prescriptions, and transparent price comparison each punch a hole in a gate that used to be the only door.
Public capacity can be rebuilt. A state can audit its own books; a public purchaser can bargain; a public manufacturer can make what the market will not. None of this requires capital's permission.
Law has tools. Antitrust can break vertical stacks; patent reform can end evergreening; procurement transparency can end the outsource.
What remains is a fight on three fronts — dismantle the stack in eyewear, reform patents and purchasing in medicine, rebuild public audit and open verification in government — but all three are the same fight: take the gate back from the party paid at the gate.